Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Summary
Postpartum depression is a common psychological abnormality during the puerperium, which seriously affects maternal and neonatal health. Esketamine, the S-enantiomer of ketamine, is twice as potent as ketamine and can be safely used for cesarean section and labor analgesia. However, it is not clear whether esketamine used for epidural labor analgesia can significantly reduce the incidence of postpartum depression. This study intends to explore the incidence of maternal prenatal depression and to investigate the effect of esketamine for epidural labor analgesia on postpartum depression and maternal and neonatal outcomes in parturients with prenatal depression through a multi-center, large-scale and high-quality clinical trail, in order to provide a clinical basis and theoretical basis for the application of esketamine used for epidural labor analgesia in postpartum depression and further reduce the incidence of postpartum depression, promote maternal and infant health, and ensure maternal and infant safety .
Official title: Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression and Maternal and Neonatal Outcomes in Parturients With Prenatal Depression
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
364
Start Date
2023-05-01
Completion Date
2025-12-31
Last Updated
2024-08-20
Healthy Volunteers
No
Conditions
Interventions
Esketamine
The drug esketamine will be added to the experimental group as opposed to the control group.
Sufentanil
Sufentanil for labour analgesia in the control group
Locations (1)
Women's hospital, school of medicine, Zhejiang university
Hangzhou, Zhejiang, China